Research Article
Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively
Figure 1
Expression levels for the six miRNAs in the plasma from PDAC patients and control individuals. (a)–(f) represent miR-21, miR-210, miR-155, miR-196a, miR-20a, and miR-25.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |